Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · IEX Real-Time Price · USD

1.24

-0.04 (-3.13%)

Dec 29, 2023, 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Revenue	292.48	211.65	294.64	335	207.74	181.23	1.54	0	0	0	Upgrade
Revenue Growth (YoY)	38.19%	-28.17%	-12.05%	61.26%	14.63%	11706.32%	-	-	-	-	Upgrade
Cost of Revenue	85.57	150.67	296.48	145.34	7.77	0	0	0	0	0	Upgrade
Gross Profit	206.92	60.98	-1.83	189.67	199.97	181.23	1.54	0	0	0	Upgrade
Selling, General & Admin	138.6	174.14	154.1	149.46	87.06	27.01	22.21	18.5	14.68	7.03	Upgrade
Research & Development	129.99	147.85	218.49	322.97	291.01	230.89	115.79	43.02	23.26	8.9	Upgrade
Other Operating Expenses	19.11	3.49	3.41	3.53	0.07	0	0	0	0	0	Upgrade
Operating Expenses	287.7	325.48	375.99	475.95	378.14	257.9	138	61.51	37.94	15.93	Upgrade
Operating Income	-80.78	-264.5	-377.83	-286.29	-178.16	-76.67	-136.46	-61.51	-37.94	-15.93	Upgrade
Interest Expense / Income	15.69	19.94	8.87	-0.79	-6.15	0	0	0	0	0	Upgrade
Other Expense / Income	-2.24	-2.41	-1.86	0.79	-0.08	-3	-0.71	-0.8	-0.91	-2.77	Upgrade
Pretax Income	-94.23	-282.02	-384.84	-286.29	-171.93	-73.67	-135.75	-60.72	-37.03	-13.17	Upgrade
Income Tax	0	0	0	-6.63	-28.34	0	0	0	0	0	Upgrade
Net Income	-94.23	-282.02	-384.84	-279.66	-143.59	-73.67	-135.75	-60.72	-37.03	-13.17	Upgrade
Preferred Dividends	0	0	0	0	0	0	0	0	86.9	55.89	Upgrade
Net Income Common	-94.23	-282.02	-384.84	-279.66	-143.59	-73.67	-135.75	-60.72	-123.93	-69.05	Upgrade
Shares Outstanding (Basic)	183	166	138	118	58	44	38	26	15	1	Upgrade
Shares Outstanding (Diluted)	183	166	138	118	58	44	38	26	15	1	Upgrade
Shares Change	10.14%	19.85%	16.95%	104.00%	33.42%	15.33%	42.49%	71.81%	2732.05%	31.37%	Upgrade
EPS (Basic)	-0.52	-1.70	-2.78	-2.36	-2.47	-1.69	-3.60	-2.29	-8.04	-126.94	Upgrade
EPS (Diluted)	-0.52	-1.70	-2.78	-2.36	-2.47	-1.69	-3.60	-2.29	-8.04	-126.94	Upgrade
Free Cash Flow	-73.27	-253.02	-110.71	-264.1	-99.1	-57.78	55.24	-52.82	-27.71	-11.35	Upgrade
Free Cash Flow Per Share	-0.40	-1.52	-0.80	-2.23	-1.71	-1.33	1.47	-2.00	-1.80	-20.87	Upgrade
Gross Margin	70.74%	28.81%	-0.62%	56.62%	96.26%	100.00%	100.00%	-	-	-	Upgrade
Operating Margin	-27.62%	-124.97%	-128.23%	-85.46%	-85.76%	-42.31%	-8889.90%	-	-	-	Upgrade
Profit Margin	-32.22%	-133.25%	-130.61%	-83.48%	-69.12%	-40.65%	-8843.45%	-	-	-	Upgrade
Free Cash Flow Margin	-25.05%	-119.55%	-37.57%	-78.83%	-47.70%	-31.88%	3598.96%	-	-	-	Upgrade
EBITDA	-43.26	-225.96	-343.32	-250.67	-175.66	-73.05	-135.45	-60.62	-36.99	-13.17	Upgrade
EBITDA Margin	-14.79%	-106.76%	-116.52%	-74.83%	-84.56%	-40.31%	-8824.17%	-	-	-	Upgrade
Depreciation & Amortization	35.28	36.13	32.66	36.42	2.42	0.62	0.3	0.1	0.05	0	Upgrade
EBIT	-78.54	-262.09	-375.97	-287.08	-178.08	-73.67	-135.75	-60.72	-37.03	-13.17	Upgrade
EBIT Margin	-26.85%	-123.83%	-127.60%	-85.70%	-85.72%	-40.65%	-8843.45%	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).